In this study, we show that CTSD is highly expressed in AML, especially in the monocytic AML, which promotes AML progression by maintaining the stability of the anti-apoptotic proteins BCL2, BCL-XL, and MCL1. Here, CTSD is linked to acute myeloid leukemia.